Macroheterocylic compounds useful as kinase inhibitors

Details for Australian Patent Application No. 2002227371 (hide)

Owner Ortho-McNeil Pharmaceutical, Inc.

Inventors Shah, Chandra, R; Prouty, Catherine; Deangelis, Alan; Lan, Shen; White, Kimberly, B.; Shah, Chandra, R; Murray, William, V.; Zhang, Han-Cheng; Demarest, Keith; Connolly, Peter; Maryoff, Bruce, E.; Kuo, Gee-Hong; Conway, Bruce

Agent Shelston IP

Pub. Number AU-B-2002227371

PCT Pub. Number WO02/46197

Priority 60254161 08.12.00 US

Filing date 6 December 2001

Wipo publication date 18 June 2002

Acceptance publication date 10 May 2007

International Classifications

C07D 498/22 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/4162 (2006.01) - condensed with heterocyclic ring systems

A61K 31/437 (2006.01)

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 Drugs for disorders of the nervous system

Event Publications

10 May 2007 Application Accepted

  Published as AU-B-2002227371

6 September 2007 Standard Patent Sealed

25 October 2007 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Maryoff, Bruce E. to Maryanoff, Bruce E.

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002227372-Method of sterilizing and initiating a scavenging reaction in a package

2002227370-DUAL LANE CONVEYING APPARATUS